CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis
NCT06785519
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Lupus Nephritis
Interventions
BIOLOGICAL:
CD19/BCMA Lupus Nephritis Targeted CAR T-cells injection
Sponsor
He Huang
Collaborators
[object Object]